Rajanikanth Gopika, Prangley Asher, Stransky Olivia M, Langfelder-Schwind Elinor, Vento Jodie, Felter Elizabeth, Kazmerski Traci M
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Department of Pediatrics, School of Medicine, University of Pittsburgh Pittsburgh, PA, USA.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251340334. doi: 10.1177/17534666251340334. Epub 2025 May 28.
People with cystic fibrosis (pwCF) are increasingly considering their reproductive options. Currently, there are many genetic testing options available for pwCF and their reproductive partners. Healthcare providers, including genetic counselors, can educate pwCF about these options and support them through the decision-making process.
This study explored the role of genetics in the reproductive decisions of pwCF and their perspectives and experiences surrounding prenatal and preconception genetic counseling and testing.
We conducted a qualitative study of a national US sample of pwCF age ⩾18 years recruited from the CF Foundation Community Voice platform.
We conducted and recorded semi-structured telephone interviews with participants. We utilized Dedoose software and applied inductive thematic analysis to code the interview transcripts and elicit themes.
We interviewed 21 participants (76.2% women, 95.2% White, 4.8% Hispanic, 57.1% parents, 23.8% considering parenthood). Key themes included: (1) pwCF appeared to understand the genetics of CF and were typically first introduced to CF genetics by CF providers, school, or their parents; (2) pwCF had diverse perspectives on having a child with CF; (3) carrier testing was an important consideration for some participants when making decisions about biological parenthood; (4) participants understood the role of genetic counselors and valued their knowledge, but only half previously met with a genetic counselor; (5) pwCF believed genetics information should be presented during childhood/adolescence and reinforced when interested in family planning.
pwCF have discrepant views on passing on CF to future offspring, and although there is recognition of the role of genetic counseling and a desire for knowledge from genetic testing, genetic considerations are but one factor involved in parenthood decisions. Future work should develop patient-, provider-, or system-based interventions to best integrate high-quality genetics and genetic counseling care into the CF team for those with CF considering parenthood.
囊性纤维化患者(pwCF)越来越多地在考虑他们的生育选择。目前,有许多基因检测选项可供pwCF及其生育伴侣选择。包括遗传咨询师在内的医疗保健提供者可以向pwCF介绍这些选项,并在决策过程中为他们提供支持。
本研究探讨了遗传学在pwCF生育决策中的作用,以及他们对产前和孕前遗传咨询与检测的看法和经历。
我们对从囊性纤维化基金会社区声音平台招募的年龄≥18岁的美国全国性pwCF样本进行了定性研究。
我们对参与者进行了半结构化电话访谈并录音。我们使用Dedoose软件并应用归纳主题分析对访谈记录进行编码并引出主题。
我们采访了21名参与者(76.2%为女性,95.2%为白人,4.8%为西班牙裔,57.1%为父母,23.8%正在考虑为人父母)。关键主题包括:(1)pwCF似乎了解囊性纤维化的遗传学知识,通常是由囊性纤维化医疗服务提供者、学校或他们的父母首先向他们介绍囊性纤维化遗传学的;(2)pwCF对生育患有囊性纤维化的孩子有不同的看法;(3)对于一些参与者来说,在决定亲生父母身份时,携带者检测是一个重要的考虑因素;(4)参与者理解遗传咨询师的作用并重视他们的知识,但只有一半的人之前见过遗传咨询师;(5)pwCF认为遗传学信息应该在儿童期/青少年期提供,并在对计划生育感兴趣时得到强化。
pwCF对于将囊性纤维化遗传给后代有不同的看法,尽管人们认识到遗传咨询的作用以及对基因检测知识的渴望,但遗传因素只是生育决策中涉及的一个因素。未来的工作应该开发基于患者、医疗服务提供者或系统的干预措施,以便为那些考虑生育的囊性纤维化患者将高质量的遗传学和遗传咨询护理最好地整合到囊性纤维化治疗团队中。